Welcome to MutualFunds.com. Please help us personalize your experience.
Your personalized experience is almost ready.
Thank you!
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission, we hope you enjoy your experience
Under normal market conditions, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.
Sign up for Advisor Access to receive email updates about ETIHX competitors, news, CE accredited webcasts and more.
| Period | ETIHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 48.9% | 9.2% | 48.9% | 0.85% |
| 1 Yr | 25.3% | -18.6% | 25.8% | 1.69% |
| 3 Yr | 23.4%* | -12.2% | 28.3% | 1.80% |
| 5 Yr | 15.8%* | -11.2% | 15.8% | 0.95% |
| 10 Yr | N/A* | -1.9% | 16.9% | N/A |
* Annualized
| Period | ETIHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2018 | -6.9% | -25.3% | 21.5% | 42.34% |
| 2017 | 43.9% | -10.8% | 43.9% | 0.92% |
| 2016 | -16.0% | -31.6% | 6.9% | 50.94% |
| 2015 | 13.8% | -20.4% | 13.8% | 0.97% |
| 2014 | 29.3% | -5.8% | 31.5% | 5.21% |
| Period | ETIHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 48.9% | 9.2% | 48.9% | 0.85% |
| 1 Yr | 25.3% | -18.6% | 33.9% | 2.54% |
| 3 Yr | 24.0%* | -12.2% | 28.3% | 2.70% |
| 5 Yr | 16.4%* | -11.2% | 17.8% | 2.86% |
| 10 Yr | N/A* | -1.9% | 18.0% | N/A |
* Annualized
| Period | ETIHX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2018 | -6.9% | -25.3% | 22.2% | 50.45% |
| 2017 | 45.8% | -10.8% | 45.8% | 0.92% |
| 2016 | -16.0% | -26.4% | 8.7% | 65.09% |
| 2015 | 15.2% | -16.6% | 15.2% | 0.97% |
| 2014 | 29.3% | -5.8% | 36.7% | 20.83% |
| ETIHX | Category Low | Category High | ETIHX % Rank | |
|---|---|---|---|---|
| Net Assets | 944 M | 2.62 M | 45.1 B | 56.69% |
| Number of Holdings | 62 | 26 | 388 | 77.95% |
| Net Assets in Top 10 | 450 M | 857 K | 17.4 B | 50.39% |
| Weighting of Top 10 | 41.56% | 20.8% | 75.3% | 40.16% |
| Weighting | Return Low | Return High | ETIHX % Rank | |
|---|---|---|---|---|
| Stocks | 94.10% | 90.21% | 103.54% | 95.28% |
| Other | 3.81% | -27.41% | 3.81% | 0.79% |
| Cash | 2.09% | 0.00% | 9.79% | 36.22% |
| Preferred Stocks | 0.00% | 0.00% | 1.43% | 33.07% |
| Convertible Bonds | 0.00% | 0.00% | 1.54% | 23.62% |
| Bonds | 0.00% | 0.00% | 20.60% | 23.62% |
| Weighting | Return Low | Return High | ETIHX % Rank | |
|---|---|---|---|---|
| Healthcare | 92.64% | 56.60% | 99.67% | 85.04% |
| Industrials | 1.45% | 0.00% | 2.40% | 2.36% |
| Utilities | 0.00% | 0.00% | 0.00% | 15.75% |
| Technology | 0.00% | 0.00% | 16.35% | 61.42% |
| Real Estate | 0.00% | 0.00% | 5.81% | 22.83% |
| Financial Services | 0.00% | 0.00% | 6.37% | 36.22% |
| Energy | 0.00% | 0.00% | 0.43% | 19.69% |
| Communication Services | 0.00% | 0.00% | 1.02% | 16.54% |
| Consumer Defense | 0.00% | 0.00% | 33.15% | 28.35% |
| Consumer Cyclical | 0.00% | 0.00% | 10.49% | 25.98% |
| Basic Materials | 0.00% | 0.00% | 1.66% | 35.43% |
| Weighting | Return Low | Return High | ETIHX % Rank | |
|---|---|---|---|---|
| US | 83.42% | 58.43% | 99.93% | 43.31% |
| Non US | 10.68% | 0.00% | 39.77% | 64.57% |
| ETIHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.29% | 0.10% | 4.94% | 47.01% |
| Management Fee | 1.10% | 0.09% | 1.30% | 90.55% |
| 12b-1 Fee | 0.00% | 0.00% | 1.00% | 1.39% |
| Administrative Fee | 0.10% | 0.01% | 0.40% | 37.50% |
| ETIHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 2.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
| ETIHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | 1.00% | 0.75% | 2.00% | 43.90% |
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| ETIHX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 53.00% | 0.00% | 341.00% | 71.19% |
| ETIHX | Category Low | Category High | ETIHX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 3.94% | 33.07% |
| ETIHX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Quarterly | Annually |
| ETIHX | Category Low | Category High | ETIHX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -1.19% | -2.24% | 2.12% | 91.45% |
| ETIHX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Start Date
Tenure
Tenure Rank
Dec 27, 2012
6.85
6.9%
Finny Kuruvilla, M.D., Ph.D., has been primarily responsible for the day-to-day management of the Gilead Fund and Healthcare & Life Sciences Fund since inception. Dr. Kuruvilla has been the Managing Partner of the Adviser since its inception in 2008. Dr. Kuruvilla possesses a diverse background in quantitative methods, with applications focused on innovations in science, engineering, and medicine. He holds an MD from Harvard Medical School, a PhD in Chemistry and Chemical Biology from Harvard University, a master’s degree in Electrical Engineering and Computer Science from MIT, and a bachelor’s degree from Caltech in Chemistry. From 2005-2008, Dr. Kuruvilla was a clinical fellow at the Brigham and Women's Hospital and a postdoctoral scientist at MIT. As an avid proponent of values-based investing, Dr. Kuruvilla has established rigorous standards in seeking out the most ethical companies at the outset of the stock selection process. In addition to his role with the Adviser, Dr. Kuruvilla is a founder, financial sponsor, and Board Director of Sattler College, a four-year college in Boston, Massachusetts, opened in 2018. Dr. Kuruvilla also contributes to the college in a limited faculty role. From 2008-2016, Dr. Kuruvilla provided research services as an employee of Clarus Ventures, a healthcare and life sciences venture capital firm. From 2006-2008, Dr. Kuruvilla was a research fellow at the Broad Institute of Harvard and MIT.
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.34 | 22.14 | 9.7 | 19.51 |
TAXATION
For mutual fund investors, taxes are inevitable. Even if you’re a long-term buy...
MUTUAL FUND EDUCATION
Many investors assume that changes in a mutual fund’s net asset value (NAV)...
MUTUAL FUND EDUCATION
For investors looking to add mutual funds to their portfolio, they need to...
